DK2561876T3 - Formuleringer af deoxycholsyre og salte deraf - Google Patents

Formuleringer af deoxycholsyre og salte deraf

Info

Publication number
DK2561876T3
DK2561876T3 DK11178538.2T DK11178538T DK2561876T3 DK 2561876 T3 DK2561876 T3 DK 2561876T3 DK 11178538 T DK11178538 T DK 11178538T DK 2561876 T3 DK2561876 T3 DK 2561876T3
Authority
DK
Denmark
Prior art keywords
formulations
salts
deoxycholic acid
deoxycholic
acid
Prior art date
Application number
DK11178538.2T
Other languages
English (en)
Inventor
Robert Emil Hodge
Jeffrey Douglas Webster
Robert M Moriarty
Original Assignee
Kythera Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kythera Biopharmaceuticals Inc filed Critical Kythera Biopharmaceuticals Inc
Application granted granted Critical
Publication of DK2561876T3 publication Critical patent/DK2561876T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK11178538.2T 2011-08-23 2011-08-23 Formuleringer af deoxycholsyre og salte deraf DK2561876T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11178538.2A EP2561876B1 (en) 2011-08-23 2011-08-23 Formulations of Deoxycholic Acid and Salts Thereof

Publications (1)

Publication Number Publication Date
DK2561876T3 true DK2561876T3 (da) 2014-07-21

Family

ID=44651163

Family Applications (2)

Application Number Title Priority Date Filing Date
DK11178538.2T DK2561876T3 (da) 2011-08-23 2011-08-23 Formuleringer af deoxycholsyre og salte deraf
DK17188946.2T DK3305298T3 (da) 2011-08-23 2011-08-23 Formuleringer af deoxycholsyre og salte deraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK17188946.2T DK3305298T3 (da) 2011-08-23 2011-08-23 Formuleringer af deoxycholsyre og salte deraf

Country Status (11)

Country Link
EP (4) EP3305298B1 (da)
CY (1) CY1115372T1 (da)
DK (2) DK2561876T3 (da)
ES (3) ES2738500T3 (da)
HR (1) HRP20140676T1 (da)
HU (1) HUE046047T2 (da)
PL (2) PL2561876T3 (da)
PT (2) PT2561876E (da)
RS (1) RS53419B (da)
SI (1) SI2561876T1 (da)
SM (1) SMT201400094B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
US20120237492A1 (en) 2011-02-18 2012-09-20 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
US20170119794A1 (en) * 2015-11-04 2017-05-04 Kythera Biopharmaceuticals, Inc. Treatments of accumulated fat with deoxycholic acid and salts thereof
CN118005707A (zh) * 2024-01-18 2024-05-10 山东省食品药品检验研究院 一种脱氧胆酸钠晶型a及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754709B1 (fr) 1996-10-23 1999-03-05 Sanofi Sa Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
US6417179B1 (en) * 1998-10-13 2002-07-09 Craig G. Burkhart Ear wax solution
US20050048126A1 (en) * 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
ES2372499T3 (es) 2004-05-19 2012-01-20 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Uso de un detergente para la eliminación no quirúrgica de grasa.
US7754230B2 (en) 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
CA2610022A1 (en) 2005-06-06 2006-12-14 Georgetown University Compositions and methods for lipo modeling
TW201011755A (en) 2008-09-10 2010-03-16 Skymedi Corp Flash memory system and its data recovery method

Also Published As

Publication number Publication date
RS53419B (sr) 2014-12-31
ES2738500T3 (es) 2020-01-23
PL3305298T3 (pl) 2020-02-28
HRP20140676T1 (hr) 2014-10-10
SMT201400094B (it) 2014-11-10
EP2561876B1 (en) 2014-04-16
SI2561876T1 (sl) 2014-08-29
HUE046047T2 (hu) 2020-01-28
PT2561876E (pt) 2014-07-18
DK3305298T3 (da) 2019-07-29
EP3511007A1 (en) 2019-07-17
EP3305298B1 (en) 2019-05-01
EP2561876A1 (en) 2013-02-27
PT3305298T (pt) 2019-07-29
CY1115372T1 (el) 2017-01-04
EP3305298A1 (en) 2018-04-11
ES2478447T3 (es) 2014-07-22
EP2735310B1 (en) 2017-10-11
ES2655465T3 (es) 2018-02-20
PL2561876T3 (pl) 2014-09-30
EP2735310A1 (en) 2014-05-28

Similar Documents

Publication Publication Date Title
DK2892912T3 (da) C17-alkandiyl og alkenediylderivater af oleanolsyre og fremgangsmåder til anvendelse deraf
DK3235812T3 (da) Deutererede derivater af ivacaftor
DK3336097T3 (da) Fremstilling af ikke-krystallinsk obeticholsyre
IL249056B (en) Phenothiazine diaminium salts and their use
DK3050972T3 (da) Fremgangsmåder til fremstilling af eicosapentaensyre i thraustochytrider
DK3725778T4 (da) Formuleringer af enzalutamid
DK2528602T4 (da) Formuleringer af bendamustin
DK2931891T3 (da) Rna-styret modificering af menneskelige genomer
EP2852326A4 (en) INSPECTION ON SITE TO POSITION IMPLANTS
DK2892550T3 (da) Stabile vandige formuleringer af adalimumab
DK2688557T3 (da) Fremgangsmåder og sammensætninger til behandling af forstyrelse af opmærksomhed
DK2909182T3 (da) Fremstilling af og formulering omfattende en mek-inhibitor
DK2917358T3 (da) Sammensætninger og fremgangsmåder til biologisk fremstilling af fedtsyrederivater
DK2562155T3 (da) Hydroxaminsyrederivat
SMT201600272B (it) Diidropiridinoni e piperidinoni arilici come inibitori di mgat2
PL2704737T3 (pl) Terapeutyczne kompozycje nukleaz i sposoby
ZA201401027B (en) Formulations of deoxycholic acid and salts thereof
DK3831406T3 (da) Stabile formuleringer af Neisseria-Meningitidis-RLP2086-antigener
DK2931313T3 (da) Opløsningsformuleringer af manipulerede anti-il-23p19-antistoffer
HRP20160989T1 (hr) Otopina za oralnu primjenu
DK2646452T3 (da) Chlorering af carbohydrater og carbohydratderivater
DK2661274T3 (da) Sammensætninger og fremgangsmåder med aloepolysaccharider
DK2427417T3 (da) Salte af 3-pentylphenyleddikesyre og farmaceutiske anvendelser deraf
DK3498313T3 (da) Rørformede proteser
HRP20180567T1 (hr) Farmaceutski pripravak omeprazola